Amneal Pharmaceuticals, Inc.(NYSE : AMRX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.20%||157.98||0.7%||$1165.17m|
|MRK||Merck & Co., Inc.||2.10%||74.67||0.7%||$877.51m|
|BMY||Bristol-Myers Squibb Co.||0.72%||60.87||1.0%||$840.70m|
|LLY||Eli Lilly & Co.||0.33%||207.61||1.1%||$637.99m|
|KALV||KalVista Pharmaceuticals, Inc.||-1.54%||30.41||0.4%||$98.10m|
|NVO||Novo Nordisk A/S||-0.70%||69.12||0.1%||$90.72m|
|RPRX||Royalty Pharma Plc||5.95%||45.07||0.2%||$84.42m|
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.